Get startedLog in
    Picture of Bayer AG logo

    BAYN — Bayer AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Bayer's Asundexian stroke trial shows fewer ischemic events, no bleeding risk – NEJM

    Picture of Bayer AG logoBayer AG
    16/04/2026 07:34
    April 16 (Reuters) - Bayer AG BAYGn.DE:

BAYER AG - ASUNDEXIAN OCEANIC-STROKE PHASE III STUDY RESULTS

BAYER AG - STUDY RESULTS DEMONSTRATING SUBSTANTIAL REDUCTION IN ISCHEMIC STROKE WITH NO INCREASE IN ISTH MAJOR BLEEDING VERSUS PLACEBO

BAYER AG - PUBLISHED IN NEW ENGLAND JOURNAL OF MEDICINE

Source text: [ID:]

Further company coverage: [BAYGn.DE]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Bayer AG

    See all news